SUZHOU, China – A recent revision to China's legal infrastructure for the pharma industry represents a concrete step toward bolstering domestic biotech innovation, said stakeholders gathered at last weekend's China Biomed Innovation and Investment Conference.

SUZHOU, China – The Hong Kong Stock Exchange (HKEX) chief proposed to unleash China's rich data resources to advance big health care, after he steered a groundbreaking move last year to welcome pre-revenue biotech companies, a move that has become a hot topic for the industry at home and abroad.

SUZHOU, China – The rare disease space continues to be an area of focus for across the sector worldwide, and China is no exception, with regulators rolling out long-awaited incentives and drugmakers viewing the field as a promising area to drive growth.

SUZHOU, China – The global biotech market continues to look promising and Chinese companies are taking notice as they lay the foundation for new advances.

SEOUL – After a decade of steady increases, venture capital (VC) investments in South Korea's biotech sector are more active. But for the country's strategic financial plan to be sustainable, it will have to further strengthen its science capabilities, according to experts at the Korea Bio Investment Conference (KBIC) last week in Seoul.

HONG KONG – At the recent Beyond Paradigm Summit 2019 in Kuala Lumpur, a Malaysian company unveiled the country's first humanoid robot.